|
KPNA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63147273468667E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66355818009833E-12 |
| Normal-vs-Stage2 |
2.31781260850994E-12 |
| Normal-vs-Stage3 |
1.62503344114384E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.914600E-01 |
| Stage1-vs-Stage3 |
4.829800E-02 |
| Stage1-vs-Stage4 |
3.980000E-04 |
| Stage2-vs-Stage3 |
1.571750E-01 |
| Stage2-vs-Stage4 |
1.309850E-02 |
| Stage3-vs-Stage4 |
1.604820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9960036108132E-15 |
| Normal-vs-AfricanAmerican |
1.4500999999667E-06 |
| Normal-vs-Asian |
3.10862446895044E-15 |
| Caucasian-vs-AfricanAmerican |
4.224200E-02 |
| Caucasian-vs-Asian |
4.504200E-01 |
| AfricanAmerican-vs-Asian |
1.946000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
2.02060590481778E-14 |
| Male-vs-Female |
2.856100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.38618022510673E-14 |
| Normal-vs-Age(41-60Yrs) |
4.88498130835069E-15 |
| Normal-vs-Age(61-80Yrs) |
2.55351295663786E-15 |
| Normal-vs-Age(81-100Yrs) |
3.58110000000522E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.579400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.434000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.923600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.386000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.097800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.621800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.016200E-04 |
| Classical-VS-Follicular |
2.321200E-01 |
| Classical-VS-Other |
2.679600E-01 |
| Classical-VS-Normal |
1.67710290099876E-12 |
| Tall-VS-Follicular |
4.196400E-04 |
| Tall-VS-Other |
8.301800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.219600E-02 |
| Follicular-VS-Normal |
1.73938641268023E-12 |
| Other-VS-Normal |
1.06919999520727E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69864122767649E-14 |
| Normal-vs-N1 |
9.99200722162641E-16 |
| N0-vs-N1 |
6.300500E-02 |
|
|
